Study guide

11.2 Acyanotic Lesions & Respiratory Management

NBRC RRT-NPS Neonatal/Pediatric Specialist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neonatal and Pediatric Patient Assessment

1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage

2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics

3 Chapter 3: Airway Management & Secretion Clearance

3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning

4 Chapter 4: Pharmacology & Medical Gas Therapy

4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation

5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders

5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration

6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety

6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care

7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation

7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk

8 Chapter 8: High-Frequency Ventilation & Advanced Modes

8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure

9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy

9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response

10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness

10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains

11 Chapter 11: Congenital Heart Disease & Hemodynamic Management

11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS

12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care

12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation

11.2 Acyanotic Lesions & Respiratory Management

Key Takeaways Explain This Topic AI

A hemodynamically important PDA may cause a continuous murmur, bounding pulses, and wide pulse pressure. In a preterm infant, the team weighs conservative care, label- or protocol-directed drug closure, and catheter or surgical closure according to gestation, physiology, contraindications, and response.

Complete atrioventricular septal defect is strongly associated with trisomy 21. For a large left-to-right shunt, avoid unnecessary hyperoxia and hypocapnia, but use patient-specific oxygen targets and treat clinically important hypoxemia.

Qp/Qs equals (systemic arterial saturation minus mixed venous saturation) divided by (pulmonary venous saturation minus pulmonary arterial saturation), so saturations of 0.96, 0.66, 0.98, and 0.82 give a ratio of about 1.88.

Murmur loudness runs inverse to VSD severity: small restrictive defects produce loud harsh murmurs with thrills, while large unrestrictive defects equalize ventricular pressures and generate soft murmurs with severe pulmonary overcirculation.

Last updated: September 2026

11.2 Acyanotic Lesions & Respiratory Management

Clinical Comparison Table: Acyanotic Heart Lesions +--------------------+-------------------------+-------------------------+-------------------------+-------------------------+

| Cardiac Lesion | Anatomical Defect | Characteristic Murmur | Key Clinical Signs | Definitive Management |

+--------------------+-------------------------+-------------------------+-------------------------+-------------------------+

| Ventricular | Defect in ventricular | Harsh holosystolic at | Tachypnea, poor feeding,| Small: spontaneous |

| Septal Defect | septum (perimembranous, | LLSB; thrill common; | failure to thrive; loud | closure; Large: patch |

| (VSD) | muscular, inlet, outlet)| soft if unrestrictive | P2 if pulmonary HTN | surgical closure |

+--------------------+-------------------------+-------------------------+-------------------------+-------------------------+

| Atrial Septal | Defect in atrial septum | Systolic ejection at | Widely split, fixed S2; | Catheter amplatzer |

| Defect (ASD) | (ostium secundum, | LUSB (pulmonary flow); | right heart enlargement;| closure (secundum) or |

| | ostium primum, venosus) | silent across defect | dyspnea, arrhythmias | surgical patch repair |

+--------------------+-------------------------+-------------------------+-------------------------+-------------------------+

| Patent Ductus | Persistent fetal vessel | Continuous 'machinery' | Bounding pulses; wide | IV Indomethacin, IV |

  • | Arteriosus | connecting aorta to | murmur at left | pulse pressure; vent | Ibuprofen, or IV Tylenol;|
  • | (PDA) | pulmonary artery | infraclavicular area | dependency; NEC / IVH | coil / surgical ligation|

+--------------------+-------------------------+-------------------------+-------------------------+-------------------------+

| Complete AV Canal | Primum ASD + inlet VSD | Holosystolic murmur of | Down syndrome (40-50%); | Complete surgical repair|

| Defect (AVSD) | + common AV valve | AV valve regurgitation; | early CHF, pulmonary | with two-patch closure |

| | | systolic ejection at LUSB| flooding, rapid PVR rise| at 3 to 6 months of age |

+--------------------+-------------------------+-------------------------+-------------------------+-------------------------+

Hemodynamic Shunt Fraction Calculation ( Q p / Q s Q_p/Q_s Q p ​ / Q s ​ )

The ratio of pulmonary blood flow ( Q p Q_p Q p ​ ) to systemic blood flow ( Q s Q_s Q s ​ ) is one important catheterization measure of shunt magnitude. Derived from the Fick principle: Q p = V ˙ O 2 C p v O 2 − C p a O 2 and Q s = V ˙ O 2 C a O 2 − C v ˉ O 2 Q_p = \frac{\dot{V}\text{O}_2}{C_{pv\text{O}_2} - C_{pa\text{O}_2}} \quad \text{and} \quad Q_s = \frac{\dot{V}\text{O}_2}{C_{a\text{O}_2} - C_{\bar{v}\text{O}_2}} Q p ​ = C p v O 2 ​ ​ − C p a O 2 ​ ​ V ˙ O 2 ​ ​ and Q s ​ = C a O 2 ​ ​ − C v ˉ O 2 ​ ​ V ˙ O 2 ​ ​

Dividing Q p Q_p Q p ​ by Q s Q_s Q s ​ cancels out oxygen consumption ( V ˙ O 2 \dot{V}\text{O}_2 V ˙ O 2 ​ ). Assuming equal hemoglobin concentration and dissolved oxygen fractions, oxygen content values can be simplified directly to fractional oxygen saturations ( Sat \text{Sat} Sat ): Q p Q s = Sat a O 2 − Sat v ˉ O 2 Sat p v O 2 − Sat p a O 2 \frac{Q_p}{Q_s} = \frac{\text{Sat}_{a\text{O}_2} - \text{Sat}_{\bar{v}\text{O}_2}}{\text{Sat}_{pv\text{O}_2} - \text{Sat}_{pa\text{O}_2}} Q s ​ Q p ​ ​ = Sat p v O 2 ​ ​ − Sat p a O 2 ​ ​ Sat a O 2 ​ ​ − Sat v ˉ O 2 ​ ​ ​

Where:

Sat a O 2 = \text{Sat}_{a\text{O}_2} = Sat a O 2 ​ ​ = Systemic arterial oxygen saturation (aorta or systemic artery, typically 0.95 to 1.00 0.95\text{ to }1.00 0.95 to 1.00 )

Sat v ˉ O 2 = \text{Sat}_{\bar{v}\text{O}_2} = Sat v ˉ O 2 ​ ​ = Mixed systemic venous oxygen saturation (measured or estimated using the catheterization laboratory’s sampling method)

Sat p v O 2 = \text{Sat}_{pv\text{O}_2} = Sat p v O 2 ​ ​ = Pulmonary venous oxygen saturation (assumed 0.98 to 1.00 0.98\text{ to }1.00 0.98 to 1.00 on room air if unmeasured)

Sat p a O 2 = \text{Sat}_{pa\text{O}_2} = Sat p a O 2 ​ ​ = Pulmonary arterial oxygen saturation (measured downstream from the shunt)

Clinical Interpretation of Q p / Q s Q_p/Q_s Q p ​ / Q s ​

Q p / Q s = 1.0 Q_p/Q_s = 1.0 Q p ​ / Q s ​ = 1.0 : Normal balanced pulmonary and systemic blood flows (no intracardiac shunt).

Q p / Q s = 1.1 to 1.4 Q_p/Q_s = 1.1\text{ to }1.4 Q p ​ / Q s ​ = 1.1 to 1.4 : Small, restrictive left-to-right shunt; typically well-tolerated without pulmonary vascular changes.

Q p / Q s ≥ 1.5 to 2.0 Q_p/Q_s \ge 1.5\text{ to }2.0 Q p ​ / Q s ​ ≥ 1.5 to 2.0 : Often supports a hemodynamically important left-to-right shunt. Closure decisions also require symptoms, defect anatomy, chamber loading, pulmonary pressure and resistance, age, and procedural guidance; the ratio alone is not a universal mandate.

Q p / Q s < 1.0 Q_p/Q_s < 1.0 Q p ​ / Q s ​ < 1.0 : Net right-to-left shunt (indicates cyanotic congenital heart disease or Eisenmenger syndrome).

  • Worked Clinical Calculation: Hemodynamic Shunt Fraction
  • Clinical Scenario

A 4-month-old infant ( 5.2 kg 5.2\text{ kg} 5.2 kg ) with a large perimembranous VSD and poor growth undergoes diagnostic cardiac catheterization on room air ( FiO 2 = 0.21 \text{FiO}_2 = 0.21 FiO 2 ​ = 0.21 ). Blood oximetry samples reveal the following values:

Systemic arterial saturation ( Sat a O 2 \text{Sat}_{a\text{O}_2} Sat a O 2 ​ ​ ): 96 % 96\% 96% ( 0.96 0.96 0.96 )

Mixed systemic venous saturation ( Sat v ˉ O 2 \text{Sat}_{\bar{v}\text{O}_2} Sat v ˉ O 2 ​ ​ ): 66 % 66\% 66% ( 0.66 0.66 0.66 )

Pulmonary vein saturation ( Sat p v O 2 \text{Sat}_{pv\text{O}_2} Sat p v O 2 ​ ​ ): 98 % 98\% 98% ( 0.98 0.98 0.98 )

Pulmonary artery saturation ( Sat p a O 2 \text{Sat}_{pa\text{O}_2} Sat p a O 2 ​ ​ ): 82 % 82\% 82% ( 0.82 0.82 0.82 )

Step-by-Step Mathematical Calculation

Identify the equation: Q p Q s = Sat a O 2 − Sat v ˉ O 2 Sat p v O 2 − Sat p a O 2 \frac{Q_p}{Q_s} = \frac{\text{Sat}_{a\text{O}_2} - \text{Sat}_{\bar{v}\text{O}_2}}{\text{Sat}_{pv\text{O}_2} - \text{Sat}_{pa\text{O}_2}} Q s ​ Q p ​ ​ = Sat p v O 2 ​ ​ − Sat p a O 2 ​ ​ Sat a O 2 ​ ​ − Sat v ˉ O 2 ​ ​ ​

Calculate systemic arteriovenous saturation difference: Sat a O 2 − Sat v ˉ O 2 = 0.96 − 0.66 = 0.30 \text{Sat}_{a\text{O}_2} - \text{Sat}_{\bar{v}\text{O}_2} = 0.96 - 0.66 = 0.30 Sat a O 2 ​ ​ − Sat v ˉ O 2 ​ ​ = 0.96 − 0.66 = 0.30

Calculate pulmonary arteriovenous saturation difference: Sat p v O 2 − Sat p a O 2 = 0.98 − 0.82 = 0.16 \text{Sat}_{pv\text{O}_2} - \text{Sat}_{pa\text{O}_2} = 0.98 - 0.82 = 0.16 Sat p v O 2 ​ ​ − Sat p a O 2 ​ ​ = 0.98 − 0.82 = 0.16

Divide the systemic gradient by the pulmonary gradient: Q p Q s = 0.30 0.16 = 1.875 ≈ 1.88 \frac{Q_p}{Q_s} = \frac{0.30}{0.16} = 1.875 \approx 1.88 Q s ​ Q p ​ ​ = 0.16 0.30 ​ = 1.875 ≈ 1.88

Clinical Interpretation: The patient has a Q p / Q s Q_p/Q_s Q p ​ / Q s ​ of 1.88 1.88 1.88 , confirming a large, hemodynamically significant left-to-right shunt. Pulmonary blood flow is nearly double systemic blood flow. The result supports a substantial shunt, but repair requires integration of symptoms, anatomy, chamber loading, pulmonary pressure and resistance, age, and multidisciplinary assessment.

Respiratory Management in Left-to-Right Shunts

The respiratory therapist in the NICU/PICU helps manage gas exchange and lung mechanics while tracking how oxygen, ventilation, and airway pressure affect pulmonary and systemic blood flow. Changes should follow the lesion-specific plan and the patient’s response. VENTILATORY CONTROL OF THE SHUNT

  • │
  • ┌──────────────────────────┴──────────────────────────┐
  • ▼ ▼
  • [HYPEROXIA & HYPOCAPNIA] [CONTROLLED GAS GOALS]
  • Oxygen above prescribed need may lower PVR • Use the prescribed oxygen range
  • Unintended hypocapnia/alkalosis may lower PVR • Avoid unintended hypocapnia
  • Either change can increase pulmonary flow • Titrate PEEP to recruitment, venous
  • Effect depends on anatomy and baseline physiology return, compliance, and perfusion
  • Reassess oxygen delivery and systemic perfusion • Confirm response with clinical trends
  • 1. The Peril of Excessive Oxygenation (Hyperoxia)

Mechanism: Oxygen can lower pulmonary vascular resistance. In a patient with pulmonary overcirculation, oxygen well above the amount needed for the prescribed target may further increase pulmonary blood flow; the magnitude depends on anatomy and baseline vascular tone.

Physiological Consequence: A fall in PVR can increase left-to-right shunt flow and worsen pulmonary congestion. In a vulnerable circulation, excessive pulmonary flow may also compete with systemic flow. Track work of breathing, radiographic and lung-mechanics trends, blood pressure, urine output, lactate, and other measures of oxygen delivery.

Oxygen strategy: Use the lowest FiO2 that achieves the prescribed target and adequate systemic oxygen delivery. Avoid reflexively driving saturation to 100% when pulmonary overcirculation is a concern, but do not tolerate clinically important hypoxemia. The congenital-cardiac team individualizes the target by lesion, repair stage, hemoglobin, perfusion, and shunt balance.

2. Avoidance of Hypocapnia and Respiratory Alkalosis

Arterial carbon dioxide tension and pH are direct modulators of pulmonary vascular tone. Hypocapnia and respiratory alkalosis can lower PVR and increase pulmonary flow. Avoid unintended overventilation; set PaCO2 and pH goals from the lesion, lung disease, neurologic status, and congenital-cardiac plan rather than applying a universal range.

3. Application of Positive End-Expiratory Pressure (PEEP)

Titrate PEEP to recruit unstable lung while monitoring compliance, oxygenation, venous return, ventricular filling, and systemic perfusion. Both atelectasis and overdistension can increase PVR. No single PEEP range reliably balances every defect, and high intrathoracic pressure can reduce preload and cardiac output.

  • NPS Exam Traps
  • Exam Trap 1: The "100% Oxygen Reflex" in Tachypneic Heart Failure

An exam question presents an infant with a large VSD or PDA who presents in marked respiratory distress with tachypnea, grunting, subcostal retractions, and bilateral pulmonary crackles. The candidate is tempted to select high-flow 100% oxygen via non-rebreather mask to "treat the distress." Oxygen may be necessary, but 100% oxygen is not a treatment for tachypnea by itself and can increase pulmonary flow. Use the prescribed saturation target, assess systemic oxygen delivery and pulmonary congestion, and provide diuresis or positive pressure only when ordered and physiologically indicated.

Exam Trap 2: Murmur Intensity vs. Defect Severity

A common NBRC question asks the clinician to assess two infants with VSD: Patient A has a loud, harsh Grade 5/6 holosystolic murmur with a thrill; Patient B has a soft, faint Grade 1–2/6 murmur. The exam asks which patient has the more severe hemodynamic defect. Candidates frequently choose Patient A. In reality, Patient B has the more severe defect. Small restrictive defects generate high pressure gradients and loud murmurs with minimal shunting; large unrestrictive defects equalize RV and LV pressures, creating soft murmurs but catastrophic pulmonary flooding ( Q p / Q s > 2.0 Q_p/Q_s > 2.0 Q p ​ / Q s ​ > 2.0 ).

Exam Trap 3: Pharmacotherapy Selection with Renal Impairment or Low Platelets

When closing a hemodynamically significant PDA in a premature infant, exam items frequently note concurrent laboratory abnormalities such as a platelet count of 35 , 000 / μ L 35,000/\mu\text{L} 35 , 000/ μ L or a serum creatinine of 1.8 mg/dL 1.8\text{ mg/dL} 1.8 mg/dL . Selecting IV indomethacin or ibuprofen in this setting is an error because both drugs are COX inhibitors that worsen platelet dysfunction and induce renal vasoconstriction. The correct selection is IV acetaminophen , which acts on the peroxidase synthase site without inhibiting peripheral COX-1 or inducing renal ischemia.